Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Gynecomastia × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 2944 Carcinoma, Renal Cell 874 Urinary Bladder Neoplasms 709 Kidney Neoplasms 452 Breast Neoplasms 402 Neoplasms 389 Carcinoma, Non-Small-Cell Lung 228 Neoplasm Metastasis 227 Lung Neoplasms 215 Ovarian Neoplasms 210 Colorectal Neoplasms 200 Melanoma 192 Carcinoma, Transitional Cell 186 Testicular Neoplasms 169 Pancreatic Neoplasms 142 Sarcoma 128 Head and Neck Neoplasms 120 Colonic Neoplasms 119 Uterine Cervical Neoplasms 116 Wilms Tumor 115 Stomach Neoplasms 97 Neuroblastoma 90 Multiple Myeloma 87 Lymphoma, Non-Hodgkin 85 Esophageal Neoplasms 85 Lymphoma 83 Carcinoma, Hepatocellular 80 Carcinoma, Ovarian Epithelial 79 Squamous Cell Carcinoma of Head and Neck 74 Recurrence 74

Interventions

bicalutamide 1 Tamoxifen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00637871 2011-01-24

Casodex - Nolvadex Combination

AstraZeneca

Phase 2 Completed

Gynecomastia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡